119 related articles for article (PubMed ID: 24214617)
21. T cell recognition of haptens, a molecular view.
Martin S; Weltzien HU
Int Arch Allergy Immunol; 1994 May; 104(1):10-6. PubMed ID: 7524836
[TBL] [Abstract][Full Text] [Related]
22. Interactions of chemicals and metal ions with proteins and role for immune responses.
Martin SF; Merfort I; Thierse HJ
Mini Rev Med Chem; 2006 Mar; 6(3):247-55. PubMed ID: 16515463
[TBL] [Abstract][Full Text] [Related]
23. The molecular basis of T-cell specificity.
Matis LA
Annu Rev Immunol; 1990; 8():65-82. PubMed ID: 1693083
[TBL] [Abstract][Full Text] [Related]
24. Molecular modeling of a T-cell receptor bound to a major histocompatibility complex molecule: implications for T-cell recognition.
Almagro JC; Vargas-Madrazo E; Lara-Ochoa F; Horjales E
Protein Sci; 1995 Sep; 4(9):1708-17. PubMed ID: 8528069
[TBL] [Abstract][Full Text] [Related]
25. The role of cell surface recognition structures in the initiation of MHC-unrestricted 'promiscuous' killing by T cells.
Thiele DL; Lipsky PE
Immunol Today; 1989 Nov; 10(11):375-81. PubMed ID: 2532884
[TBL] [Abstract][Full Text] [Related]
26. HLA-restricted recognition of viral antigens in HLA transgenic mice.
Kievits F; Ivanyi P; Krimpenfort P; Berns A; Ploegh HL
Nature; 1987 Oct 1-7; 329(6138):447-9. PubMed ID: 2821399
[TBL] [Abstract][Full Text] [Related]
27. Identification of Dermatophagoides farinae-2-derived peptides and class II HLA molecules recognized by T cells from atopic individuals.
Inoue R; Matsuoka T; Kondo N; Nishimura Y; Matsushita S
Int Arch Allergy Immunol; 1997 Dec; 114(4):354-60. PubMed ID: 9414139
[TBL] [Abstract][Full Text] [Related]
28. Suboptimal recognition of a T cell epitope of the major dog allergen Can f 1 by human T cells.
Juntunen R; Liukko A; Taivainen A; Närvänen A; Durand G; Kauppinen A; Nieminen A; Rytkönen-Nissinen M; Saarelainen S; Maillère B; Virtanen T; Kinnunen T
Mol Immunol; 2009 Oct; 46(16):3320-7. PubMed ID: 19700193
[TBL] [Abstract][Full Text] [Related]
29. Molecular docking predictions of fragrance binding to human leukocyte antigen molecules.
Schutte RJ; Zhang X; An N; Ostrov DA; Vukmanović S
Contact Dermatitis; 2019 Sep; 81(3):174-183. PubMed ID: 30957232
[TBL] [Abstract][Full Text] [Related]
30. Recognition of core and flanking amino acids of MHC class II-bound peptides by the T cell receptor.
Sant'Angelo DB; Robinson E; Janeway CA; Denzin LK
Eur J Immunol; 2002 Sep; 32(9):2510-20. PubMed ID: 12207335
[TBL] [Abstract][Full Text] [Related]
31. Intercellular and intracellular events following the MHC-unrestricted TCR recognition of a tumor-specific peptide epitope on the epithelial antigen MUC1.
Magarian-Blander J; Ciborowski P; Hsia S; Watkins SC; Finn OJ
J Immunol; 1998 Apr; 160(7):3111-20. PubMed ID: 9531265
[TBL] [Abstract][Full Text] [Related]
32. Dermatophagoides farinae-1-derived peptides and HLA molecules recognized by T cells from atopic individuals.
Matsuoka T; Kohrogi H; Ando M; Nishimura Y; Matsushita S
Int Arch Allergy Immunol; 1997 Apr; 112(4):365-70. PubMed ID: 9104792
[TBL] [Abstract][Full Text] [Related]
33. Limited plasticity in T cell recognition of modified T cell receptor contact residues in MHC class II bound peptides.
de Haan EC; Wagenaar-Hilbers JP; Liskamp RM; Moret EE; Wauben MH
Mol Immunol; 2005 Feb; 42(3):355-64. PubMed ID: 15589324
[TBL] [Abstract][Full Text] [Related]
34. What guides MHC-restricted TCR recognition?
Mazza C; Malissen B
Semin Immunol; 2007 Aug; 19(4):225-35. PubMed ID: 17521918
[TBL] [Abstract][Full Text] [Related]
35. Human TCR-MHC coevolution after divergence from mice includes increased nontemplate-encoded CDR3 diversity.
Chen X; Poncette L; Blankenstein T
J Exp Med; 2017 Nov; 214(11):3417-3433. PubMed ID: 28835417
[TBL] [Abstract][Full Text] [Related]
36. Major histocompatibility complex class II-associated peptides determine the binding of the superantigen toxic shock syndrome toxin-1.
von Bonin A; Ehrlich S; Malcherek G; Fleischer B
Eur J Immunol; 1995 Oct; 25(10):2894-8. PubMed ID: 7589089
[TBL] [Abstract][Full Text] [Related]
37. Molecular basis of drug recognition by specific T-cell receptors.
von Greyerz S; Burkhart C; Pichler WJ
Int Arch Allergy Immunol; 1999 Jul; 119(3):173-80. PubMed ID: 10436388
[TBL] [Abstract][Full Text] [Related]
38. Correlation of contact sensitizer potency with T cell frequency and TCR repertoire diversity.
Esser PR; Kimber I; Martin SF
Exp Suppl; 2014; 104():101-14. PubMed ID: 24214621
[TBL] [Abstract][Full Text] [Related]
39. T cell antigen receptor recognition of antigen-presenting molecules.
Rossjohn J; Gras S; Miles JJ; Turner SJ; Godfrey DI; McCluskey J
Annu Rev Immunol; 2015; 33():169-200. PubMed ID: 25493333
[TBL] [Abstract][Full Text] [Related]
40. MHC class I-peptide interactions and TCR recognition.
Young AC; Zhang W; Sacchettini JC; Nathenson SG
Cancer Surv; 1995; 22():17-36. PubMed ID: 7536627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
